A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
AB0288 PERSISTENTLY ACTIVE DISEASE IN PATIENTS WITH NEW-ONSET RHEUMATOID ARTHRITIS DURING THE FIRST YEAR OF TIGHT CONTROL AND AGGRESSIVE THERAPY: PREVALENCE AND CLINICAL PREDICTORS IN DIFFERENT CRITERIA SETS
2019
Abstracts Accepted for Publication
unpublished
Early intervention and aggressive therapy of rheumatoid arthritis (RA) improves prognosis, however a substantial proportion of patients under guideline-based care remain persistently active disease (PAD) in the first year. Objectives: To investigate the proportion of PAD (LDA/MDA/HDA) in reallife practice and identify its prognostic factors in early RA (£2 years) patients receiving tight-controlled conventional synthetic disease-modifying antirheumatic drugs (csDMARD) treatment at 1 year of
doi:10.1136/annrheumdis-2019-eular.947
fatcat:3lqnu762k5appg2witu4n4nkve